East Tennessee State University

Digital Commons @ East Tennessee State University
Undergraduate Honors Theses

Student Works

5-2016

In Vitro Investigation of the Effect of Exogenous
Ubiquitin on Processes Associated with
Atherosclerosis
Chase W. Mussard
East Tennessee State University

Follow this and additional works at: https://dc.etsu.edu/honors
Part of the Biochemistry Commons, Cardiovascular System Commons, Cell Biology Commons,
Cells Commons, Circulatory and Respiratory Physiology Commons, Medical Cell Biology
Commons, and the Molecular Biology Commons
Recommended Citation
Mussard, Chase W., "In Vitro Investigation of the Effect of Exogenous Ubiquitin on Processes Associated with Atherosclerosis"
(2016). Undergraduate Honors Theses. Paper 327. https://dc.etsu.edu/honors/327

This Honors Thesis - Withheld is brought to you for free and open access by the Student Works at Digital Commons @ East Tennessee State University.
It has been accepted for inclusion in Undergraduate Honors Theses by an authorized administrator of Digital Commons @ East Tennessee State
University. For more information, please contact digilib@etsu.edu.

In Vitro Investigation of the Effect of Exogenous Ubiquitin
on Processes Associated with Atherosclerosis
By
Chase Wilkes Mussard

An Undergraduate Thesis Submitted in Partial Fulfillment
of the Requirements for the
University Honors Scholars Program
East Tennessee State University

___________________________________________
Chase W. Mussard
Date

___________________________________________
Dr. Douglas Thewke, Thesis Mentor
Date

___________________________________________
Dr. David Johnson, Reader
Date

___________________________________________
Dr. Antonio Rusinol, Reader
Date

March 31, 2016

In Vitro Investigation of the Effect of
Exogenous Ubiquitin on Processes
Associated with Atherosclerosis
Chase Mussard
Department of Biomedical Sciences
Quillen College of Medicine
East Tennessee State University
Johnson City, Tennessee

ABSTRACT
Atherosclerosis, characterized by the build-up of cholesterol, immune cells and cellular
debris within arterial walls, is accelerated following myocardial infarction by poorly understood
mechanisms. Ubiquitin, a small, well-studied intracellular protein involved in protein turnover
via the proteasome pathway, has recently been shown to exert extracellular effects on cardiac
myocytes, in vitro, and in mice undergoing myocardial remodeling. This study investigates the
potential role of extracellular ubiquitin in atherosclerosis by determining its effects on two
critical atherosclerotic processes: the migration of vascular smooth muscles cells and the uptake
of modified LDL by monocyte/macrophages in foam cell formation. In the presence of ubiquitin,
smooth muscle cell migration was accelerated and foam cell formation was enhanced, suggesting
that ubiquitin has an active role in atherosclerosis.
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BACKGROUND and INTRODUCTION
Cardiovascular disease, commonly known as heart disease, is the leading cause of death
in the United States. Approximately 600,000 individual deaths each year are associated with this
disease, or roughly 25% of all associated deaths. One of the most common forms of this disease
is coronary heart disease, a disease affecting the blood supply to cardiac tissue2. Atherosclerosis
is the underlying mechanism that drives the progression of cardiovascular disease. Characterized
as a chronic inflammatory disease, atherosclerosis is marked by the hardening and thickening of
arterial walls due to a buildup of cellular debris within them, called plaque3.

Figure 1. Physiological representation of
atherosclerosis. Atherosclerosis is generally
known as the hardening of arterial walls due
to plaque buildup. As seen left, normal flow is
indicated in the top vessel, with little to no
plaque buildup. The middle vessel shows an
early stage atherosclerosis in which
significant plaque buildup occurs, narrowing
the arterial flow. The bottom vessel displays a
ruptured plague resulting in a blood clot with
blocked arterial flow, triggering myocardial
infarction or stroke. (Image from Yeadon
2015)1

Atherosclerosis, in later stages of progression, can lead to major, life threatening clinical
events, such as myocardial infarction (heart attack) and stroke3. When a plaque becomes large
enough to rupture through the wall and into the vessel, thrombus (blood clotting) occurs around
the ruptured plaque and blood flow can be reduced or possibly blocked completely by the
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thrombus, or at a location downstream if the clot breaks free in the blood. When blood flow is
reduced or blocked in a specific area of the body, the potential for tissue damage and death rises
dramatically.
There are several cell types and biomolecules that are major components of
atherosclerosis, including vascular smooth muscle cells, monocyte/macrophage cells, and lowdensity lipoproteins. The arterial walls where atherosclerosis occurs are composed of vascular
smooth muscles, not to be confused with cardiac myocytes, or cardiac muscle. Vascular smooth
muscle cells comprise the deep muscular layer of the walls of arteries and vessels, which
function to transport blood throughout the body. Monocytes are a specific type of leukocyte
(white blood cell) that are major components of the body’s inflammatory immune response in
plaque buildup4. Monocytes that are differentiated to uptake and digest foreign material and
cellular debris are called macrophages. One other important component of atherosclerosis is lowdensity lipoproteins or LDL. LDL is the major transportation molecule for cholesterol, which is
incorporated into cell membranes and used for various biomolecular processes5. LDL, with
bound cholesterol, is commonly referred to as “bad cholesterol”, as opposed to HDL (highdensity lipoprotein) “good cholesterol”, which is responsible for removal and recycling of
cholesterol.
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Figure 2. Atherosclerosis displayed in its entire pathophysiological progression. (A) Lesion formation represents early
stages of disease. (B) Fatty streak represents foam cell formation. (C) Fibrous plaque represents necrotic death, plaque
progression, and subsequent stabilization via vascular smooth muscle cell proliferation and migration. (D) Thrombosis
indicates the potential risk of late stage atherosclerosis, which is plaque rupture and clotting, leading to myocardial
infarction or stroke. (Image adapted from Steinl et al 2015)6

The cellular mechanism of atherosclerosis involves many steps that are important to
understanding the underlying pathophysiology of heart disease. In the first stages of
atherosclerosis (Figure 2 – Lesion Initiation), an individual typically will have a higher than
normal amount of cholesterol in the blood. Derived from diet or endogenous synthesis,
cholesterol is a major component of eukaryotic cellular membranes. Thus, it is understandable
that the body has a need for large amounts of cholesterol. However, higher amounts of unutilized cholesterol in blood serum can lead to atherosclerosis. Cholesterol is transported through
the body via blood by two major transport molecules, low-density lipoprotein (LDL) and highdensity lipoprotein (HDL), respectively referred to as “good” and “bad” cholesterol. These large
4
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lipid rich transport proteins carry cholesterol through the body. LDL, or “bad” cholesterol,
contains a higher amount of lipids such as cholesterol, while HDL or “good” cholesterol contains
less lipid and more protein. LDL functions to deposit cholesterol in target tissue, and HDL,
conversely, functions to remove cholesterol from a target tissue. Under normal physiological
conditions, these processes are happening simultaneously and in a balanced manner as to not
allow too much deposition or withdrawal. However, when LDL concentration is too high,
atherosclerosis can occur.
When blood exits the heart and travels through the aorta, it encounters many branches or
bifurcations, such as the coronary arteries. In these areas of bifurcation, the arterial flow is under
high velocity and pressure. Due to not well understood pathophysiological reasons, these areas
are more prone to be the site of atherosclerotic lesions than other areas, which explains why
myocardial infarction is a major risk of late stage atherosclerosis7. High concentrations of LDL
in the blood increases its likelihood of deposition in the arterial walls in areas of bifurcation,
such as branching of the coronary artieries7. When this LDL is deposited into the walls, it can
become modified, for example, by oxidation reactions via various free radicals in the intima of
the wall or by local cell-mediated processes5. Once oxidized, LDL is extremely difficult to
remove. Recognizing an increase in oxidized LDL (oxLDL) as a “foreign” presence, local tissue
will begin secreting signaling molecules called cytokines5 (Figure 2 – Fatty Streak). Cytokines
are specialized to activate and trigger an inflammatory immune response. These cytokines will
activate leukocytes in the blood, specifically monocytes, to migrate into the arterial walls at the
affected area4. Once in the wall, monocytes will differentiate into macrophages, specialized
scavenger immune cells designed to ingest foreign material invading in the body. The
macrophages ingest the oxLDL for metabolic processing and removal. The processing of oxLDL
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involves the disassembly of the LDL particles and storage of the cholesterol as cholesterol esters
in lipid-rich droplets inside the cell4. The continued uptake of oxLDL leads to accumulation of
these lipid-rich droplets within the macrophage resulting in them becoming “foam cells” due to
their foamy appearance when viewed under light microscopy compared to surrounding tissue.
Foam cell formation is considered by most to be the hallmark of atherosclerosis3-5, 7. If the rate of
LDL deposition and subsequent oxidation is happening to such as large degree that the HDL in
local tissue cannot respond adequately to the demand for removal of cholesterol, the
inflammation continues with more recruitment of monocytes to the area which subsequently
become foam cells. This accumulation of foam cells results in the formation of “fatty streaks”
along the vessel wall and is the first visible stage of plaque formation.
Physiologically, the local tissue goes a step further to help attenuate this process (Figure
2 – Fibrous Plaque). At a certain point, foam cells will actually loose viability and die, unable to
meet the demand for oxLDL removal. This can occur via apoptosis, which is a programmed cell
death in which internal contents are digested and packaged for surrounding tissue to ingest8.
Important to note that this does not cause any further damage to surrounding cells. However, cell
death can also occur dramatically in the form of necrosis, which is simply the bursting of a cell
and the release of all its contents into local interstitial space due to overwhelming stress. This
process is dangerous for local tissue as it can cause further inflammation in the tissue8. Foam cell
death in atherosclerosis occurs both ways. Necrotic death of foam cells is thought to be another
contributing mechanism behind the oxidation of native LDL to oxLDL, which can further
accelerate the inflammatory response and atherosclerosis5. Foam cell death can lead to large
necrotic and fatty debris concentrations in the arterial wall. The local tissue will then begin
stabilizing the debris, or plaque, by recruiting vascular smooth muscle cells (VSMC) in the wall
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to proliferate and migrate over the plaque and secrete an extracellular matrix to form a fibrous
cap over the plaque9. VSMC migration occurs throughout later stages of atherosclerosis and is a
critical component of the formation of a stable plaque. The fibrous-rich extracellular matrix
secreted by the VSMC functions to attenuate further plaque buildup and provide a barrier
between the highly thrombogenic molecules in the necrotic plaque and clotting factors in the
blood9.
Atherosclerosis will continue to progress as long as the deposition of LDL in the artery
wall stimulates the inflammatory response. If the fibrous cap erodes, the plaque may rupture
through the arterial wall into the blood stream (Figure 2 – Thrombosis). When this happens,
thrombus formation is triggered via activation of platelets in the serum10. This rupture and
subsequent clot formation can either reduce or block flow in the immediate vessel. If flow is
blocked, downstream tissue death occurs as blood supply is completely stopped. If this occurs in
the coronary arteries, a myocardial infarction (heart attack) occurs and clots that break loose can
travel to the brain and cause a stroke. A myocardial infarction increases the risk for additional
MI’s due to acceleration of the atherosclerotic process, at least partly due to stimulation of the
inflammatory responses driving plaque progression 11. Overall, atherosclerosis is best understood
to be an inflammatory process designed to attenuate LDL deposition in arterial walls and to
stabilize plaques against rupture.

Ubiquitin, as its name implies, is a universally present protein of approximately 8.5 kDa
found in all eukaryotic cells. It is highly conserved, fluctuating on average by only 2-3 amino
acid residues across all known species. Ubiquitin plays a well-known role intracellularly in the
post-translational modification of proteins12. In common cellular processes, such as protein
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turnover and apoptosis, ubiquitinylation is utilized as a tag for protein degradation by the
proteasome pathway.

Figure 3. Ubiquitin is a highly conserved protein with well-studied intracellular
function in the post-translational protein modification process, but its
extracellular function is not well understood. Above is 3D model of ubiquitin.
(Image adapted from Ramage et al 1994)13

Extracellularly, however, ubiquitin’s role is poorly understood. It is known to be present
in serum, cerebral spinal fluid, and urine under normal physiological conditions 14. However, the
finding that extracellular levels of ubiquitin increase during some disease states has led to more
recent investigations into its extracellular function. In patients that have suffered an acute
myocardial infarction, serum ubiquitin concentrations were found to be increased threefold 15.
Using this as a basis, another study showed that ubiquitin was an active modulator of myocardial
remodeling, the process by which cardiac tissue adapts following a myocardial infarction 12, 16.
Although the involvement of ubiquitin in modulating atherosclerosis is unknown, several lines of
evidence suggest a potential function of ubiquitin in either the initiation and/or progression of
plaque formation. Ubiquitin binds with specificity to a G-protein coupled surface receptor, CXC
8
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Chemokine Receptor 4, (CXCR4) 17 in a manner similar to a typical chemokine interaction,
suggesting a potential mediator of ubiquitin signaling 18. Primary human leukocytes (the
monocytes active in foam cell formation) and human vascular smooth muscle cells, both express
the CXCR4 receptor 19. Studies conducted in mouse models have shown that CXCR4 and its
chemokine ligand, CXCL12, function in the initiation and progression of atherosclerosis20, 21.

Figure 4. Ubiquitin has been demonstrated and investigated to confirm its specific receptor binding characteristics
with C-X-C Chemokine Receptor 4, commonly referred to as CXCR4. Above is a representation of Ubiquitin
interacting with the CXCR4 receptor. (Image adapted from Saini et al 2011)18

Thus, we hypothesize that ubiquitin signaling plays a role in atherosclerosis and to begin
to test this hypothesis, we proposed the following two aims:
AIM 1:

To examine the potential role of ubiquitin in the initiation of atherosclerosis by evaluating

the effect of exogenous ubiquitin on monocyte/macrophage foam cell formation in vitro.

AIM 2:

To examine the potential role of ubiquitin in the progression of atherosclerosis by

determining the effect of exogenous ubiquitin on the migration of vascular smooth muscle cells
in vitro.
9
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METHODS AND MATERIALS

Foam Cell Assay:
RAW264.7 cells, a murine monocyte/macrophage cell line, were purchased from
American Type Culture Collection (ATCC, VA, USA). Cells were plated on 35mm tissue culture
plates at a density of 200,000 cells/mL, in standard growth media (Dulbecco’s Modified Eagle’s
Media, containing 10% fetal bovine serum, 100 U/ml penicillin and 100 µg/ml streptomycin).
All cells were incubated at 37°C in 10% CO2 / 95% air humidified atmosphere. Cells were
grown overnight to ~50% confluence and then divided into four groups as follows: Control (oxLDL/-ubiquitin), Baseline (+ 50 µg/ml oxLDL), Ubiquitin 10 (10 µg/mL ubiquitin + 50 µg/ml
oxLDL), and Ubiquitin 20 (20 µg/mL ubiquitin + 50 µg/ml oxLDL). The cells were serum
starved for 24hr prior to treatments. Ubiquitin (BostonBiochem, Cambridge, MA) was added
from 100 µg/ml stock solutions made in sterile phosphate buffered saline (PBS) one hour prior to
addition of oxLDL (Alfa Aesar, Ward Hill, MA) from 2 mg/ml stock solutions. After 24 hours,
cells were fixed in 10% buffered formalin solution, rinsed with PBS and stained with Oil-Red-O,
a dye for intracellular neutral lipids22. Lipid droplet formation was examined using a model
BX41 Olympus light microscope equipped with a Micropublisher 5.0 cooled RTV digital camera
(Qimaging). The percent of Oil-red O positive cells in photomicrographs was determined by
counting four randomly selected fields of 10x magnification (~200 total cells/field) for each
treatment. Statistical differences were determined by 2-tailed, unpaired Student t-test using
SigmaPlot software (SPSS Inc.) with P<0.05 considered statistically significant.
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Smooth Muscle Cell Migration (Scratch) Assay:
MOVAS-1 cells (a transformed murine vascular aortic smooth muscle cell line) were
purchased from the American Type Culture Collection (ATCC, VA, USA) and maintained in
modified DMEM (ATCC #30-2002) containing 4.5 g/L D-Glucose, 1.5 g/L sodium bicarbonate
and supplemented with 10% FBS, 0.2 mg/ml G-418, 100U/ml penicillin, and 100 µg/ml
streptomycin in a 10% CO2 / 95% air humidified atmosphere. Cells were plated on 35mm tissue
culture plates at a density of 200,000 cells/plate and cultured in standard growth media until they
formed a confluent monolayer. The plates were divided into three groups and ubiquitin added as
follows: Control (no ubiquitin), Ubiquitin 10 (10 µg/mL ubiquitin), and Ubiquitin 20 (20 µg/mL
ubiquitin) ubiquitin. Following 24hr in the presence of ubiquitin, a sterile pipette tip was used to
make a scratch of uniform width across the cell monolayer on each plate. Each scratch was
digitally documented using a model BX41 Olympus light microscope equipped with a
Micropublisher 5.0 cooled RTV digital camera (Qimaging). The cells were incubated for
another 12h prior to a second digital photograph. The width of each scratch at time 0h and time
12h was measured at six different points along the length of the scratch using computer-assisted
morphometric analysis (ImageJ, NIH, Bethesda, MD). The migration distance was calculated by
subtracting the mean width of a scratch at time 0h from the mean width recorded at time 12h,
divided by two. Statistical differences were determined by 2-tailed, unpaired Student t-test using
SigmaPlot software (SPSS Inc) with P<0.05 considered statistically significant.

11

BCDE

In Vitro Investigation of the Effect of Exogenous Ubiquitin on Processes Associated with Atherosclerosis

RESULTS
The hallmark of early atherosclerosis is the formation of macrophage-derived foam cells.
Cultured macrophages can take on a foam cell phenotype when they ingest oxLDL via receptormediated mechanisms and store the oxLDL-derived cholesterol as cholesteryl esters in lipid
droplets. To assess the effect of extracellular ubiquitin on foam cell formation in vitro, we
stained oxLDL-treated RAW264.7 macrophages that had been cultured in the presence and
absence of ubiquitin with Oil-Red-O, a dye selective for intracellular neutral lipids as shown in
Figure 6. Lipid droplet formation in the cytosol was undetectable by Oil-Red-O staining of
RAW264.7 macrophages cultured in the absence of oxLDL (Figure 6A) but readily detectable in
macrophages cultured for 24hr in media containing 50 µg/ml oxLDL (Figure 6B). Culturing of
RAW264.7 cells with oxLDL in the presence of increasing concentrations of ubiquitin resulted
in dose-dependent increases in the accumulation of cytosolic lipid droplets (Figure 6C, D).
Quantitation of the percent of cells containing lipid droplets under each condition revealed that
treatment with 20 µg/ml ubiquitin resulted in a significant (~1.6 fold) increase in the percent of
cells containing lipid droplets compared to baseline controls (Figure 7).

Figure 5. Foam cell formation assay timeline. Cells are serum starved 24hr prior to ubiquitin/oxLDL treatment.
Ubiquitin treatment sets received supplementation 1hr prior to addition of oxLDL to maximize the effect, if any,
exerted during oxLDL loading. After 24hr, the cells were fixed and stained with Oil-Red-O.
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Figure 6. Representative photomicrographs of Oil-Red-O stained RAW 264.7 macrophages cultured in the presence
and absence of oxLDL and ubiquitin. Panel A) Control cells cultured in absence of oxLDL. Panel B) Baseline Cells
cultured in the presence of 50 µg/mL oxLDL. Panels C and D) Ubiquitin 10 and Ubiquitin 20 Cells cultured in the
presence of 50 µg/mL oxLDL and 10 or 20 µg/mL ubiquitin, respectively. (Magnification 10x)

Figure 7. Effect of ubiquitin on RAW 264.7 macrophage foam cell formation. Quantification of the percent of cells
positive for Oil-Red-O staining after 24hr in media supplemented with oxLDL and 0, 10 or 20 µg/mL ubiquitin as
indicated. Cells were considered positive if any Oil-Red-O staining was present inside cell, and negative if no
staining was visible. * indicates p<0.05
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To investigate the effect of ubiquitin on VSMC migration a “scratch” test was performed.
A “scratch” test involves scratching a monolayer of cells to create a gap between two cell edges,
and then measuring the width of the gap over a determined period of time. For this study, a 12hour migration rate of MOVAS-1 cells, a murine vascular aortic smooth muscle cell line, was the
primary focus (Figure 8). Cells were cultured in varying amounts of ubiquitin and scratched to
create a gap in the monolayer of cells. Images were taken initially and 12hr later to measure the
change in gap width over time. Figure 9 shows a representative scratch test assay of MOVAS-1
cells in the absence and presence of ubiquitin. Migration distance of MOVAS-1 cells cultured in
the absence of ubiquitin was used as a control (Figure 9A). Cells treated with 10 µg/mL
ubiquitin exhibited an increased migration distance compared to the control group (Figure 9B).
In the presence of 20 µg/mL ubiquitin, MOVAS-1 cells showed an enhanced migration
compared to control cells (Figure 9C). Quantitation revealed that treatment with 20 µg/mL
ubiquitin resulted in a statistically significant (~15%) increase in the mean migration distance
when compared to controls in the absence of ubiquitin (Figure 10 + 11).

Figure 8. Smooth muscle cell scratch test timeline. Monolayers are treated with ubiquitin 24hr prior to the initial
scratch and images captured. Images are captured again after 12hr for final measurements of migration.
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Figure 9. Effect of ubiquitin on migration of MOVAS-1 cells as determined by scratch assay. Representative images
caputred of time 0hr and time 12hr of a scratch test assay. Treatments were introduced 24hr prior to initial 0hr
scratch and were as follows: (A) Control, (B) 10 µg/mL ubiquitin, and (C) 20 µg/mL ubiquitin. Yellow dashed lines
indicate the margins of the gap in the monolayers. (Magnification 10x).
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A – 12 Hour Scratch

B – 12 Hour Scratch

Figure 10. Quantitation of the migration of MOVAS-1 cells in the presence of varying amounts of extracellular
ubiquitin. A and B show the results from two independent assays, and performed in triplicate. Treatment sets were
done 24hr prior to initial scratch and were as follows: Control, 10 µg/mL ubiquitin, and 20 µg/mL ubiquitin.

Figure 11. Effect of ubiquitin on MOVAS-1 cell migration expressed as percent of control mean. Smooth muscle cell
migration was studied using a scratch test assay of MOVAS-1 cell line as described in methods. Treatments were
introduced 24hr prior to initial scratch and were as follows: Control, 10 µg/mL ubiquitin, and 20 µg/mL ubiquitin. *
indicates p<0.05 versus control
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DISCUSSION
To investigate the role of extracellular ubiquitin on atherosclerosis, these in vitro studies
measured the effects of ubiquitin supplementation on two major processes associated with
atherosclerosis: 1) foam cell formation and 2) smooth muscle cell migration. Foam cell
formation is an early event in atherosclerosis and considered the hallmark of atherosclerosis,
while smooth muscle cell migration is a vital process in later stages that functions to stabilize
plaque. Ubiquitin’s role in these processes is not known; however, with recent discoveries of
ubiquitin specific receptor binding to CXCR417, 19, known elevated serum ubiquitin levels
following myocardial infarction15, and demonstrated attenuating effects in myocardial
remodeling16, suggests ubiquitin potentially plays a signaling role in atherosclerosis.
In both the foam cell formation and smooth muscle cell migration, statistically significant
results were found when ubiquitin was introduced. Foam cell formation resulting from the uptake
of oxLDL was increased as the concentration of extracellular ubiquitin increased from 10 to 20
µg/mL, with a statistically significant enhancement of Oil-Red-O positive staining in RAW
264.7 cells treated with 20 µg/mL ubiquitin, indicating an increase in foam cell formation by
ubiquitin. This was graphically represented in Figure 7. This result suggests that ubiquitin may
play a role in early atherosclerosis by enhancing oxLDL uptake via macrophage foam cell
formation. This effect of ubiquitin may provide an explanation for why myocardial infarction
accelerates subsequent atherosclerosis.
Smooth muscle cell migration was accelerated in the presence of increasing amounts of
extracellular ubiquitin, with a statistically significant acceleration of MOVAS-1 migration in
cells treated with 20 µg/mL ubiquitin. This was represented by Figure 11, showing the increase
in migration distance in 12hr periods for respective concentrations of ubiquitin. These data
17
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suggest that ubiquitin may affect later stages of atherosclerosis by altering SMC migration
during plaque stabilization, a key factor in preventing rupture and subsequent myocardial
infarction or stroke.
Previous studies found that serum ubiquitin levels were increased in some diseased states,
yet increased levels do not necessarily indicate actual involvement. Other studies in mice models
reveal ubiquitin plays a modulating role in myocardial remodeling, but the mechanism by which
it occurs is still unknown. This study found that the presence of ubiquitin plays a role in
atherosclerotic processes in vitro, as foam cell formation was enhanced and smooth muscle cell
migration accelerated. However, whether ubiquitin alters atherosclerosis in vivo and by what
mechanism remains to be investigated.
Future studies to evaluate ubiquitin’s role in atherosclerosis, and specifically the two
associated processes studied here, should include determining if the enhancement of foam cell
formation and acceleration of VSMC migration are due to ubiquitin-CXCR4 receptor interaction.
To confirm that these effects are modulated and controlled through the CXCR4 receptor, a
CXCR4 antagonist could be employed to block any effect of the CXCR4 receptor. If the
observed effects of ubiquitin are muted in the presence of CXCR4 antagonism, it would suggest
that ubiquitin acts as a modulator to these processes through the CXCR4 receptor. Other means
to gain better insight into ubiquitin’s role in atherosclerosis would be to do assays on primary
monocyte/macrophage and vascular smooth muscle cell types rather than cell lines, which would
behave more similar to in vivo environments. Even further, to investigate its role more
effectively, studies done on primary human monocyte/macrophage and vascular smooth muscle
cell types would more accurately model the human atherosclerotic process in vitro. Finally, in
vivo studies using murine models of atherosclerosis to investigate ubiquitin’s role in
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atherosclerosis would be warranted. Results from such studies would then serve as the
foundation for additional research aimed at developing ubiquitin based therapies for the
treatment of atherosclerosis in humans.
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